{
  "id": "biomarker-compliance-by-site",
  "display_name": "Biomarker Testing by Site",
  "cohort": "Biomarker Testing, by Site (2024–2025)",
  "insight_type": "Precision Medicine Utilization",
  "summary": "Significant site variation in biomarker testing: Main Campus leads at 87% while East County lags at 58%. Standardizing protocols could yield $310,000 annual opportunity.",
  "chart": {
    "type": "bar",
    "unit": "site",
    "data": [
      { "name": "Main Campus", "value": 87, "gap": 12, "highlight": false },
      { "name": "West Regional", "value": 78, "gap": 3, "highlight": false },
      { "name": "North County", "value": 72, "gap": -3, "highlight": false },
      { "name": "South Bay", "value": 68, "gap": -7, "highlight": false },
      { "name": "Downtown", "value": 62, "gap": -13, "highlight": true },
      { "name": "East County", "value": 58, "gap": -17, "highlight": true }
    ],
    "benchmark": 75,
    "nccn_target": 90
  },
  "financial_impact": {
    "annual_opportunity": "$310,000/year",
    "math": "$310,000/year = 15% avg testing gap (lagging sites) × 60 patients × $34,500 precision therapy value"
  },
  "clinical_impact": {
    "description": "Standardizing biomarker testing protocols across sites improves care equity and outcomes.",
    "metrics": [
      {
        "type": "PFS",
        "value": "+4.8 months",
        "description": "Improved progression-free survival with matched therapies"
      },
      {
        "type": "OS",
        "value": "+7.2 months",
        "description": "Overall survival benefit with biomarker-guided treatment"
      },
      {
        "type": "ORR",
        "value": "+28%",
        "description": "Higher objective response rate with targeted therapies"
      },
      {
        "type": "CT",
        "value": "+36%",
        "description": "Increased clinical trial enrollment"
      },
      {
        "type": "CE",
        "value": "-24%",
        "description": "Reduced care variation and improved equity"
      }
    ],
    "quantitative": "+7.2 months OS"
  },
  "peer_comparison": {
    "description": "Top-performing networks achieve >85% biomarker testing compliance across all practice sites through standardized protocols.",
    "peer_benchmark": 85,
    "financial_impact": {
      "annual_opportunity": "$420,000/year",
      "math": "$420,000/year = $310,000 direct therapy value + $110,000 operational efficiency"
    },
    "action_steps": [
      {
        "text": "Standardize biomarker protocols across all practice sites",
        "icon": "document"
      },
      {
        "text": "Create centralized molecular pathology service",
        "icon": "building"
      },
      {
        "text": "Implement site-specific performance dashboards",
        "icon": "chart"
      },
      {
        "text": "Develop cross-site molecular tumor board",
        "icon": "users"
      }
    ]
  },
  "weighted_score": 89,
  "action_steps": [
    {
      "text": "Implement standardized reflex testing protocols across all sites",
      "icon": "document"
    },
    {
      "text": "Deploy centralized biomarker coordinator team",
      "icon": "users"
    },
    {
      "text": "Create site-specific compliance dashboards with benchmarking",
      "icon": "chart"
    },
    {
      "text": "Develop patient education materials on biomarker testing",
      "icon": "clipboard"
    }
  ],
  "suggestions": [
    {
      "text": "Analyze site demographics for testing pattern differences",
      "icon": "search"
    },
    {
      "text": "Evaluate pathology staffing differences between sites",
      "icon": "users"
    }
  ],
  "drilldowns": [
    {
      "label": "East County Detail",
      "cohort": "East County Biomarker Testing",
      "jsonFile": "biomarker-compliance-east-county.json",
      "drilldownLevel": 2
    },
    {
      "label": "Downtown Detail",
      "cohort": "Downtown Biomarker Testing",
      "jsonFile": "biomarker-compliance-downtown.json",
      "drilldownLevel": 2
    },
    {
      "label": "By Testing Method",
      "cohort": "Biomarker Testing by Method",
      "jsonFile": "biomarker-compliance-by-method.json",
      "drilldownLevel": 1
    },
    {
      "label": "By Cancer Type",
      "cohort": "Biomarker Testing by Cancer Type",
      "jsonFile": "biomarker-compliance-by-cancer.json",
      "drilldownLevel": 1
    },
    {
      "label": "Overall Compliance",
      "cohort": "Biomarker Testing Compliance",
      "jsonFile": "biomarker-compliance.json",
      "drilldownLevel": 0
    }
  ]
} 